WO1998007855A3 - Secreted proteins and polynucleotides encoding them - Google Patents
Secreted proteins and polynucleotides encoding them Download PDFInfo
- Publication number
- WO1998007855A3 WO1998007855A3 PCT/US1997/014641 US9714641W WO9807855A3 WO 1998007855 A3 WO1998007855 A3 WO 1998007855A3 US 9714641 W US9714641 W US 9714641W WO 9807855 A3 WO9807855 A3 WO 9807855A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polynucleotides encoding
- secreted proteins
- proteins
- secreted
- polynucleotides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10510922A JP2000516816A (en) | 1996-08-23 | 1997-08-20 | Secreted proteins and polynucleotides encoding them |
EP97937331A EP0922100A2 (en) | 1996-08-23 | 1997-08-20 | Secreted proteins and polynucleotides encoding them |
AU39864/97A AU3986497A (en) | 1996-08-23 | 1997-08-20 | Secreted proteins and polynucleotides encoding them |
CA002263192A CA2263192A1 (en) | 1996-08-23 | 1997-08-20 | Secreted proteins and polynucleotides encoding them |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70193196A | 1996-08-23 | 1996-08-23 | |
US08/701,931 | 1996-08-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998007855A2 WO1998007855A2 (en) | 1998-02-26 |
WO1998007855A3 true WO1998007855A3 (en) | 1998-05-07 |
Family
ID=24819253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/014641 WO1998007855A2 (en) | 1996-08-23 | 1997-08-20 | Secreted proteins and polynucleotides encoding them |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0922100A2 (en) |
JP (1) | JP2000516816A (en) |
AU (1) | AU3986497A (en) |
CA (1) | CA2263192A1 (en) |
WO (1) | WO1998007855A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5981263A (en) * | 1997-07-21 | 1999-11-09 | Incyte Pharmaceuticals, Inc. | Human matrilin-3 |
US20020102542A1 (en) | 1997-10-07 | 2002-08-01 | Daikichi Fukushima | Polypeptide, cdna encoding the polypeptide, and use of the both |
CA2309624A1 (en) * | 1997-11-21 | 1999-06-03 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990005780A1 (en) * | 1988-11-18 | 1990-05-31 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Dopamine receptors and genes |
WO1990014432A1 (en) * | 1989-05-23 | 1990-11-29 | Genetics Institute, Inc. | A human cytokine, interleukin-9 |
EP0510691A1 (en) * | 1991-04-26 | 1992-10-28 | Osaka Bioscience Institute | DNA coding for human cell surface antigen |
WO1994007916A1 (en) * | 1992-10-07 | 1994-04-14 | Merck & Co., Inc. | Human steroid hormone receptor neri |
WO1996017925A1 (en) * | 1994-12-06 | 1996-06-13 | Immunex Corporation | Cytokine designated lerk-7 |
US5536637A (en) * | 1993-04-07 | 1996-07-16 | Genetics Institute, Inc. | Method of screening for cDNA encoding novel secreted mammalian proteins in yeast |
WO1997007198A2 (en) * | 1995-08-11 | 1997-02-27 | Genetics Institute, Inc. | Dna sequences and secreted proteins encoded thereby |
WO1997025427A1 (en) * | 1996-01-12 | 1997-07-17 | Genetics Institute, Inc. | Beta-chemokine, h1305 (mcp-2) |
-
1997
- 1997-08-20 JP JP10510922A patent/JP2000516816A/en active Pending
- 1997-08-20 AU AU39864/97A patent/AU3986497A/en not_active Abandoned
- 1997-08-20 CA CA002263192A patent/CA2263192A1/en not_active Abandoned
- 1997-08-20 EP EP97937331A patent/EP0922100A2/en not_active Withdrawn
- 1997-08-20 WO PCT/US1997/014641 patent/WO1998007855A2/en not_active Application Discontinuation
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990005780A1 (en) * | 1988-11-18 | 1990-05-31 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Dopamine receptors and genes |
WO1990014432A1 (en) * | 1989-05-23 | 1990-11-29 | Genetics Institute, Inc. | A human cytokine, interleukin-9 |
EP0510691A1 (en) * | 1991-04-26 | 1992-10-28 | Osaka Bioscience Institute | DNA coding for human cell surface antigen |
WO1994007916A1 (en) * | 1992-10-07 | 1994-04-14 | Merck & Co., Inc. | Human steroid hormone receptor neri |
US5536637A (en) * | 1993-04-07 | 1996-07-16 | Genetics Institute, Inc. | Method of screening for cDNA encoding novel secreted mammalian proteins in yeast |
WO1996017925A1 (en) * | 1994-12-06 | 1996-06-13 | Immunex Corporation | Cytokine designated lerk-7 |
WO1997007198A2 (en) * | 1995-08-11 | 1997-02-27 | Genetics Institute, Inc. | Dna sequences and secreted proteins encoded thereby |
WO1997025427A1 (en) * | 1996-01-12 | 1997-07-17 | Genetics Institute, Inc. | Beta-chemokine, h1305 (mcp-2) |
Non-Patent Citations (7)
Title |
---|
ADAMS M D ET AL: "3,400 NEW EXPRESSED SEQUENCE TAGS IDENTIFY DIVERSITY OF TRANSCRIPTS IN HUMAN BRAIN", NATURE GENETICS, vol. 4, no. 3, pages 256 - 267, XP000611495 * |
JACOBS K ET AL: "A novel method for isolating eukaryotic cDNA clones encoding secreted proteins.", KEYSTONE SYMPOSIUM ON DENDRITIC CELLS: ANTIGEN PRESENTING CELLS OF T AND B LYMPHOCYTES, TAOS, NEW MEXICO, USA, MARCH 10-16, 1995. JOURNAL OF CELLULAR BIOCHEMISTRY SUPPLEMENT 0 (21A). 1995. 19. ISSN: 0733-1959, XP002027246 * |
L. HILLIER ET AL.: "y172e10.s1 Homo sapiens cDNA clone 43276 3'", EMBL SEQUENCE DATABASE, 23 June 1995 (1995-06-23), HEIDELBERG, BRD, XP002049381 * |
L. HILLIER ET AL.: "zd84d09.r1 Soares fetal heart NbHH19W Homo sapiens cDNA clone 347345 5'", EMBL SEQUENCE DATABASE, 27 June 1996 (1996-06-27), HEIDELBERG, BRD, XP002049380 * |
R.J. KAUFMAN ET AL.: "Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in chinese hamster ovary cells", MOL. CELL. BIOL., vol. 9, no. 3, March 1989 (1989-03-01), ASM WASHINGTON, DC,US, pages 1233 - 1242, XP002041592 * |
R.J. KAUFMAN ET AL.: "Improved vectors for stable expression of foreign genes in mammalian cells by use of the untranslated leader sequence from EMC virus", NUCLEIC ACIDS RESEARCH, vol. 19, no. 16, 1991, IRL PRESS LIMITED,OXFORD,ENGLAND, pages 4485 - 4490, XP002041594 * |
R.J. KAUFMAN ET AL.: "The phosphorylation state of eucaryotic initiation factor 2 alters translation efficiency of specific mRNAs", MOL. CELL. BIOL., vol. 9, no. 3, March 1989 (1989-03-01), ASM WASHINGTON, DC,US, pages 946 - 958, XP002041593 * |
Also Published As
Publication number | Publication date |
---|---|
AU3986497A (en) | 1998-03-06 |
EP0922100A2 (en) | 1999-06-16 |
JP2000516816A (en) | 2000-12-19 |
CA2263192A1 (en) | 1998-02-26 |
WO1998007855A2 (en) | 1998-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1998007859A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998017687A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1997007198A3 (en) | Dna sequences and secreted proteins encoded thereby | |
WO1999057132A8 (en) | Secreted proteins and polynucleotides encoding them | |
AU3381797A (en) | Secreted proteins and polynucleotides encoding them | |
WO1998033916A8 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998004693A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998042739A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998042741A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998055614A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998040486A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998027205A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998005776A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1999058642A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998046757A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998037094A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998032853A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998040404A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998056909A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998021332A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998030589A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998041539A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998024905A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998007855A3 (en) | Secreted proteins and polynucleotides encoding them | |
WO1998001554A3 (en) | Secreted proteins and polynucleotides encoding them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2263192 Country of ref document: CA Ref country code: CA Ref document number: 2263192 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1998 510922 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1997937331 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1997937331 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997937331 Country of ref document: EP |